Concerns about the lack of balanced information provided about left atrial appendage (LAA) closure procedures on the web pages of top US hospitals have been raised by a new study. The researchers ...
SAN FRANCISCO -- Surprisingly, a course of direct oral anticoagulation (DOAC) may be the safer choice for antithrombotic treatment after left atrial appendage (LAA) occlusion, according to the ANDES ...
Results of the Embolic Protection in Patients with Atrial Fibrillation (PROTECT-AF) showed that in AF patients who were candidates for warfarin therapy, device closure of the LAA using the Watchman ...
The global left atrial appendage closure (LAAC) devices market is projected to register a robust growth from 2025 to 2033.
The ink is barely dry on the draft Medicare physician fee schedule for 2026, but three cardiology societies blasted the draft for cutting rates for left atrial appendage closure procedures – a move ...
Medical Device Network on MSN
Gore acquires Conformal Medical to broaden endovascular portfolio
Under the acquisition, Gore will inherit Conformal’s CLAAS AcuForm system for left atrial appendage closure to mitigate stroke risk.
MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and ...
Patients with atrial fibrillation (AF) and a history of breakthrough stroke—an ischemic stroke that occurs despite use of oral anticoagulation—have a heightened risk for subsequent cerebrovascular ...
MASON, Ohio--(BUSINESS WIRE)-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback